At least 10 physicians received more than $20,000 in payments and other transfers of value from biotechnology giant Amgen in the first quarter of this year, according to newly public data published by the company. FULL STORY »
Dr. Nogah Haramati, a radiologist based in New York, recently cancelled a meeting with a vendor—one of the many equipment manufacturers and software developers who routinely offer free dinners and lectures to ply their wares. FULL STORY »
The CMS and Medicare beneficiaries could have saved an estimated $510 million on drugs used to treat end-stage renal disease in 2011 if the reimbursement rate more accurately reflected current usage of these drugs, according to a report from HHS' inspector general's office. FULL STORY »
By Beth Kutscher | March 30, 2013
| Print Magazine
Some of the nation's largest for-profit hospital chains are sitting on mounting cash piles, suggesting to analysts that a wave of dealmaking may be in the offing. FULL STORY »
By Merrill Goozner | February 02, 2013
| Print Magazine
Legislators in Washington all claim they want to hold down healthcare spending, recognizing it is the main driver of the nation's long-term deficit. FULL STORY »
By Beth Kutscher | January 05, 2013
| Print Magazine
Less than one month after the Government Accountability Office called on the CMS to recalculate payments to dialysis providers, the fiscal cliff compromise sets in motion cuts that would squeeze out $4.9 billion in savings. FULL STORY »
Victory Pharma has entered into an $11.4 million settlement to resolve allegations that it used pricey trips, tickets and dinners to entice physicians to prescribe its products. FULL STORY »
A federal judge accepted biotechnology giant Amgen's guilty plea that it illegally marketed its anemia drug Aranesp, clearing the way for a $762 million settlement agreement. FULL STORY »
Amgen, the world's largest biotechnology firm, pleaded guilty in federal court in New York to criminal charges that it illegally misbranded its anemia drug Aranesp and agreed to pay $762 million. FULL STORY »
Dialysis and kidney-care providers are taking issue with a GAO report released this month that found the government may be over-paying for end-stage renal disease treatment. FULL STORY »
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.
